› Forums › General Melanoma Community › Melanoma Molecular Disease Model
- This topic has 4 replies, 2 voices, and was last updated 14 years, 3 months ago by
MichaelFL.
- Post
-
- May 31, 2011 at 6:19 am
LONG and Interesting Article which will have running on-line updates.http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0018257
Abstract:
While advanced melanoma remains one of the most challenging cancers, recent developments in our understanding of the molecular drivers of this disease have uncovered exciting opportunities to guide personalized therapeutic decisions. Genetic analyses of melanoma have uncovered several key molecular pathways that are involved in disease onset and progression, as well as prognosis. These advances now make it possible to create a “Molecular Disease Model” (MDM) for melanoma that classifies individual tumors into molecular subtypes (in contrast to traditional histological subtypes), with proposed treatment guidelines for each subtype including specific assays, drugs, and clinical trials. This paper describes such a Melanoma Molecular Disease Model reflecting the latest scientific, clinical, and technological advances.
- Replies
-
-
- May 31, 2011 at 10:38 am
Jerry, thanks for posting this, it gives a good overview of Melanoma subtypes. Although there is much more to learn the understanding has progressed a long way in just a few years. It wasn't that long ago that all Melanoma patients were treated the same way.
best wishes
James
-
- May 31, 2011 at 10:38 am
Jerry, thanks for posting this, it gives a good overview of Melanoma subtypes. Although there is much more to learn the understanding has progressed a long way in just a few years. It wasn't that long ago that all Melanoma patients were treated the same way.
best wishes
James
-
Tagged: cutaneous melanoma
- You must be logged in to reply to this topic.